MX353795B - Coleccion y metodos para su uso. - Google Patents
Coleccion y metodos para su uso.Info
- Publication number
- MX353795B MX353795B MX2013005614A MX2013005614A MX353795B MX 353795 B MX353795 B MX 353795B MX 2013005614 A MX2013005614 A MX 2013005614A MX 2013005614 A MX2013005614 A MX 2013005614A MX 353795 B MX353795 B MX 353795B
- Authority
- MX
- Mexico
- Prior art keywords
- collections
- collection
- methods
- developability
- antigen
- Prior art date
Links
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 210000004602 germ cell Anatomy 0.000 abstract 1
- 238000002823 phage display Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41536710P | 2010-11-19 | 2010-11-19 | |
| EP10191910 | 2010-11-19 | ||
| US201161494452P | 2011-06-08 | 2011-06-08 | |
| PCT/EP2011/070473 WO2012066129A1 (en) | 2010-11-19 | 2011-11-18 | A collection and methods for its use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013005614A MX2013005614A (es) | 2013-11-21 |
| MX353795B true MX353795B (es) | 2018-01-30 |
Family
ID=44041472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013005614A MX353795B (es) | 2010-11-19 | 2011-11-18 | Coleccion y metodos para su uso. |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US8367586B2 (enExample) |
| EP (1) | EP2640742B1 (enExample) |
| JP (1) | JP6253986B2 (enExample) |
| KR (1) | KR101938021B1 (enExample) |
| CN (1) | CN103237809B (enExample) |
| AU (1) | AU2011331129B2 (enExample) |
| CA (1) | CA2816558C (enExample) |
| DK (1) | DK2640742T3 (enExample) |
| ES (1) | ES2696548T3 (enExample) |
| HR (1) | HRP20181811T1 (enExample) |
| IL (1) | IL226364B (enExample) |
| MX (1) | MX353795B (enExample) |
| NZ (1) | NZ609707A (enExample) |
| PL (1) | PL2640742T3 (enExample) |
| RU (1) | RU2603080C2 (enExample) |
| SG (2) | SG189950A1 (enExample) |
| WO (1) | WO2012066129A1 (enExample) |
| ZA (1) | ZA201303566B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102993305B (zh) | 2012-11-16 | 2015-05-13 | 上海赛伦生物技术有限公司 | 人源抗人表皮生长因子受体抗体及其编码基因与应用 |
| PL3046412T3 (pl) * | 2013-09-18 | 2019-11-29 | Regeneron Pharma | Przekształcone histydyną łańcuchy lekkie przeciwciał i genetycznie zmodyfikowane zwierzęta inne niż człowiek do ich wytwarzania |
| WO2015089080A2 (en) | 2013-12-09 | 2015-06-18 | Adimab, Llc | Polyclonal mixtures of antibodies, and methods of making and using them |
| CA2935143C (en) * | 2013-12-27 | 2024-05-07 | Chugai Seiyaku Kabushiki Kaisha | Method for purifying antibody having low isoelectric point |
| DK3416983T3 (en) | 2016-02-19 | 2021-06-21 | Morphosys Ag | Antistoffer for il-17c |
| EP3443087B1 (en) * | 2016-04-12 | 2024-09-18 | Medimmune, LLC | Immune repertoire mining |
| WO2018087349A1 (en) | 2016-11-14 | 2018-05-17 | Morphosys Ag | Fab molecules with a rodent hinge region and a non-rodent ch1 region |
| WO2019099454A2 (en) | 2017-11-15 | 2019-05-23 | Philippe Valadon | Highly functional antibody libraries |
| US11542329B2 (en) | 2018-05-16 | 2023-01-03 | Morphosys Ag | Antibodies targeting Glycoprotein VI |
| KR102115300B1 (ko) * | 2018-06-01 | 2020-05-26 | 재단법인 목암생명과학연구소 | 항체 라이브러리 및 이를 이용한 항체 스크리닝 방법 |
| JP2023526477A (ja) | 2020-05-20 | 2023-06-21 | アンスティテュ・クリー | 合成単一ドメインライブラリー |
| EP4154004A1 (en) | 2020-06-08 | 2023-03-29 | Immundiagnostik AG | Improved method and test system for in-vitro determination of drug antibodies in blood |
| JP2023542209A (ja) | 2020-09-24 | 2023-10-05 | モルフォシス・アーゲー | ヒトｃｄ３イプシロンに結合する新規なヒト抗体 |
| EP4496812A1 (en) | 2022-03-22 | 2025-01-29 | MorphoSys AG | Deimmunized antibodies specific for cd3 |
| WO2024236163A1 (en) | 2023-05-17 | 2024-11-21 | Morphosys Ag | T cell receptor beta constant region 2 (trbc2) antibodies |
| WO2025003511A1 (en) | 2023-06-30 | 2025-01-02 | Morphosys Ag | Dual-targeting of flt3 and cd123 co-expressing tumor cells by functional complementation of cycat® halfbody molecules |
| WO2025082777A1 (en) | 2023-10-17 | 2025-04-24 | Morphosys Ag | Dual-targeting of muc16 and mesothelin co-expressing tumor cells by functional complementation of cycat® halfbody molecules |
Family Cites Families (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5618920A (en) | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
| US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5258498A (en) | 1987-05-21 | 1993-11-02 | Creative Biomolecules, Inc. | Polypeptide linkers for production of biosynthetic proteins |
| AU612370B2 (en) | 1987-05-21 | 1991-07-11 | Micromet Ag | Targeted multifunctional proteins |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| ATE151110T1 (de) | 1988-09-02 | 1997-04-15 | Protein Eng Corp | Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen |
| ATE102631T1 (de) | 1988-11-11 | 1994-03-15 | Medical Res Council | Klonierung von immunglobulin sequenzen aus den variabelen domaenen. |
| AU652539B2 (en) | 1989-05-16 | 1994-09-01 | Medical Research Council | Co-expression of heteromeric receptors |
| US6291161B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertiore |
| CA2016841C (en) | 1989-05-16 | 1999-09-21 | William D. Huse | A method for producing polymers having a preselected activity |
| US6291159B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for producing polymers having a preselected activity |
| US6291160B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for producing polymers having a preselected activity |
| US6291158B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertoire |
| CA2016842A1 (en) | 1989-05-16 | 1990-11-16 | Richard A. Lerner | Method for tapping the immunological repertoire |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| US5780225A (en) | 1990-01-12 | 1998-07-14 | Stratagene | Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules |
| AU7247191A (en) | 1990-01-11 | 1991-08-05 | Molecular Affinities Corporation | Production of antibodies using gene libraries |
| DE4002897A1 (de) | 1990-02-01 | 1991-08-08 | Behringwerke Ag | Herstellung und verwendung von genbanken synthetischer menschlicher antikoerper ("synthetische human-antikoerper-bibliotheken") |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| WO1992020791A1 (en) | 1990-07-10 | 1992-11-26 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| ATE363532T1 (de) | 1991-03-01 | 2007-06-15 | Dyax Corp | Verfahren zur herstellung bindender miniproteine |
| WO1992015678A1 (en) | 1991-03-01 | 1992-09-17 | Stratagene | Pcr generated dicistronic dna molecules for producing antibodies |
| US5830663A (en) | 1991-08-10 | 1998-11-03 | Medical Research Council | In situ recombinant PCR within single cells |
| US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| EP0605522B1 (en) | 1991-09-23 | 1999-06-23 | Medical Research Council | Methods for the production of humanized antibodies |
| ATE408012T1 (de) | 1991-12-02 | 2008-09-15 | Medical Res Council | Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken |
| US5667988A (en) | 1992-01-27 | 1997-09-16 | The Scripps Research Institute | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| US5395750A (en) | 1992-02-28 | 1995-03-07 | Hoffmann-La Roche Inc. | Methods for producing proteins which bind to predetermined antigens |
| CA2131151A1 (en) | 1992-03-24 | 1994-09-30 | Kevin S. Johnson | Methods for producing members of specific binding pairs |
| US5855885A (en) | 1993-01-22 | 1999-01-05 | Smith; Rodger | Isolation and production of catalytic antibodies using phage technology |
| CA2175579A1 (en) | 1993-10-26 | 1995-05-04 | Chang Yi Wang | Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics |
| US20010049107A1 (en) | 1994-01-31 | 2001-12-06 | Boston University | Polyclonal antibody libraries |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| EP0873363B1 (en) | 1995-06-14 | 2010-10-06 | The Regents of The University of California | High affinity human antibodies to tumor antigens |
| DE69621940T2 (de) | 1995-08-18 | 2003-01-16 | Morphosys Ag | Protein-/(poly)peptidbibliotheken |
| US6696248B1 (en) | 1995-08-18 | 2004-02-24 | Morphosys Ag | Protein/(poly)peptide libraries |
| GB9603507D0 (en) | 1996-02-20 | 1996-04-17 | Isis Innovation | Antibody variants |
| JP2002501721A (ja) | 1997-08-01 | 2002-01-22 | モルフォシス・アクチェンゲゼルシャフト | 多量体（ポリ）ペプチドコンプレックスのメンバーをコードする核酸配列を同定するための新規方法およびファージ |
| GB9722131D0 (en) | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
| EP1157041B1 (en) | 1999-03-01 | 2005-06-01 | Genentech, Inc. | Antibodies for cancer therapy and diagnosis |
| ES2327382T3 (es) | 1999-07-20 | 2009-10-29 | Morphosys Ag | Metodos para presentar (poli)peptidos/proteinas en particulas de bacteriofagos a traves de enlaces disulfuro. |
| IL136459A0 (en) | 2000-05-30 | 2001-06-14 | Galim Galil Immunology Ltd | Antibody library |
| PT2316940E (pt) | 2000-12-18 | 2013-10-16 | Dyax Corp | Bibliotecas orientadas de pacotes genéticos |
| US7117096B2 (en) | 2001-04-17 | 2006-10-03 | Abmaxis, Inc. | Structure-based selection and affinity maturation of antibody library |
| AU2002330162B2 (en) | 2001-10-01 | 2008-08-07 | Takeda Pharmaceutical Company Limited | Multi-chain eukaryotic display vectors and uses thereof |
| GB0130267D0 (en) | 2001-12-19 | 2002-02-06 | Neutec Pharma Plc | Focussed antibody technology |
| US20050037358A1 (en) | 2001-12-21 | 2005-02-17 | Serge Muyldermans | Method for cloning of variable domain sequences |
| US7244592B2 (en) | 2002-03-07 | 2007-07-17 | Dyax Corp. | Ligand screening and discovery |
| US8206977B2 (en) | 2002-07-30 | 2012-06-26 | Morphosys Ag | Tricistronic vectors and uses therefor |
| US8557743B2 (en) | 2002-09-05 | 2013-10-15 | Dyax Corp. | Display library process |
| GB0309126D0 (en) | 2003-04-17 | 2003-05-28 | Neutec Pharma Plc | Clostridium difficile focussed antibodies |
| EP2325339A3 (en) | 2003-09-09 | 2011-11-02 | Integrigen, Inc. | Methods and compositions for generation of germline human antibody genes |
| TWI333977B (en) | 2003-09-18 | 2010-12-01 | Symphogen As | Method for linking sequences of interest |
| EP2343321A1 (en) | 2003-11-12 | 2011-07-13 | Patrys Limited | Human antibodies specific for carcinoma |
| US20080003566A1 (en) | 2004-01-26 | 2008-01-03 | David Vaux | Molecular Analysis |
| DE502005011243D1 (de) | 2004-05-26 | 2011-05-26 | Fraunhofer Ges Forschung | Isolation allergen-spezifischer immunoglobulin-gene aus humanen b-zellen von atopikern |
| CA2572961C (en) | 2004-07-06 | 2016-08-16 | Bioren, Inc. | Universal antibody libraries |
| US7977050B2 (en) | 2004-09-02 | 2011-07-12 | Bioarray Solutions, Ltd. | Nucleic acid amplification with integrated multiplex detection |
| US20060078898A1 (en) | 2004-10-12 | 2006-04-13 | Curry Bo U | Methods and compositions for reducing label variation in array-based comparative genome hybridization assays II |
| EP1848672A4 (en) | 2005-02-01 | 2009-11-04 | Morphosys Ag | LIBRARIES AND METHOD FOR ISOLATING ANTIBODIES |
| RU2311927C2 (ru) * | 2005-08-15 | 2007-12-10 | Федеральное государственное унитарное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека" | КОМБИНАТОРНАЯ ФАГМИДНАЯ БИБЛИОТЕКА ОДНОЦЕПОЧЕЧНЫХ АНТИТЕЛ ЧЕЛОВЕКА, ОБОГАЩЕННАЯ АНТИТЕЛАМИ ПРОТИВ ВИРУСА ОСПОВАКЦИНЫ, РЕКОМБИНАНТНАЯ ФАГМИДНАЯ ДНК pHEN-2A8, СОДЕРЖАЩАЯ УНИКАЛЬНЫЙ ГЕН ОДНОЦЕПОЧЕЧНОГО АНТИТЕЛА ЧЕЛОВЕКА, СПОСОБНОГО НЕЙТРАЛИЗОВАТЬ ВИРУС ОСПОВАКЦИНЫ И ВИРУС ОСПЫ КОРОВ, И ИСКУССТВЕННОЕ ОДНОЦЕПОЧЕЧНОЕ АНТИТЕЛО ЧЕЛОВЕКА 2A8, СПОСОБНОЕ НЕЙТРАЛИЗОВАТЬ ВИРУС ОСПОВАКЦИНЫ И ВИРУС ОСПЫ КОРОВ |
| US8679490B2 (en) | 2005-11-07 | 2014-03-25 | Genentech, Inc. | Binding polypeptides with diversified and consensus VH/VL hypervariable sequences |
| NZ569359A (en) | 2005-12-20 | 2011-11-25 | Morphosys Ag | Novel collection of HCDR3 regions and uses therefor |
| CA2651111A1 (en) | 2006-05-04 | 2007-11-15 | Abmaxis Inc. | Cross-species and multi-species display systems |
| EP1918302A3 (en) * | 2006-05-18 | 2009-11-18 | AvantGen, Inc. | Methods for the identification and the isolation of epitope specific antibodies |
| CN101772574B (zh) | 2007-08-21 | 2016-01-06 | 莫佛塞斯公司 | 改良的用于二硫键形成的方法 |
| EP3753947A1 (en) * | 2007-09-14 | 2020-12-23 | Adimab, LLC | Rationally designed, synthetic antibody libraries and uses therefor |
| CA2710373A1 (en) | 2007-12-19 | 2009-07-09 | Ping Tsui | Design and generation of human de novo pix phage display libraries via fusion to pix or pvii, vectors, antibodies and methods |
| EP2088432A1 (en) | 2008-02-11 | 2009-08-12 | MorphoSys AG | Methods for identification of an antibody or a target |
| EP2100970B1 (en) | 2008-03-13 | 2017-05-10 | National Institute of Immunology | Ig genes specific oligonucleotides and uses thereof |
| WO2009114815A1 (en) | 2008-03-13 | 2009-09-17 | Dyax Corp | Libraries of genetic packages comprising novel hc cdr3 designs |
| WO2010028791A1 (en) | 2008-09-10 | 2010-03-18 | Philochem Ag | Display library for antibody selection |
| JP2012508017A (ja) | 2008-11-07 | 2012-04-05 | ファブラス エルエルシー | 抗ｄｌｌ４抗体及びその使用 |
| WO2010130824A2 (en) * | 2009-05-15 | 2010-11-18 | Morphosys Ag | Collections and uses thereof |
| CN102449149B (zh) | 2009-05-29 | 2014-04-23 | 莫佛塞斯公司 | 集合及其使用方法 |
| EP2528944B1 (en) | 2010-01-29 | 2015-08-12 | MorphoSys AG | Rodent combinatorial antibody libraries |
-
2011
- 2011-11-18 JP JP2013539286A patent/JP6253986B2/ja active Active
- 2011-11-18 SG SG2013030085A patent/SG189950A1/en unknown
- 2011-11-18 US US13/299,367 patent/US8367586B2/en active Active
- 2011-11-18 WO PCT/EP2011/070473 patent/WO2012066129A1/en not_active Ceased
- 2011-11-18 PL PL11785411T patent/PL2640742T3/pl unknown
- 2011-11-18 NZ NZ609707A patent/NZ609707A/en not_active IP Right Cessation
- 2011-11-18 MX MX2013005614A patent/MX353795B/es active IP Right Grant
- 2011-11-18 US US13/884,975 patent/US8728981B2/en active Active
- 2011-11-18 CN CN201180055462.8A patent/CN103237809B/zh active Active
- 2011-11-18 EP EP11785411.7A patent/EP2640742B1/en active Active
- 2011-11-18 AU AU2011331129A patent/AU2011331129B2/en active Active
- 2011-11-18 RU RU2013126025/10A patent/RU2603080C2/ru active
- 2011-11-18 SG SG10201509257VA patent/SG10201509257VA/en unknown
- 2011-11-18 HR HRP20181811TT patent/HRP20181811T1/hr unknown
- 2011-11-18 CA CA2816558A patent/CA2816558C/en active Active
- 2011-11-18 KR KR1020137015575A patent/KR101938021B1/ko active Active
- 2011-11-18 ES ES11785411T patent/ES2696548T3/es active Active
- 2011-11-18 DK DK11785411.7T patent/DK2640742T3/en active
-
2013
- 2013-05-16 IL IL226364A patent/IL226364B/en active IP Right Grant
- 2013-05-16 ZA ZA2013/03566A patent/ZA201303566B/en unknown
-
2014
- 2014-04-02 US US14/242,906 patent/US9541559B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2696548T3 (es) | 2019-01-16 |
| MX2013005614A (es) | 2013-11-21 |
| US20130236902A1 (en) | 2013-09-12 |
| DK2640742T3 (en) | 2018-12-03 |
| HRP20181811T1 (hr) | 2018-12-28 |
| IL226364B (en) | 2020-11-30 |
| SG189950A1 (en) | 2013-06-28 |
| RU2603080C2 (ru) | 2016-11-20 |
| CA2816558C (en) | 2020-12-29 |
| SG10201509257VA (en) | 2015-12-30 |
| NZ609707A (en) | 2014-12-24 |
| CA2816558A1 (en) | 2012-05-24 |
| JP2014500725A (ja) | 2014-01-16 |
| US9541559B2 (en) | 2017-01-10 |
| RU2013126025A (ru) | 2014-12-27 |
| ZA201303566B (en) | 2014-07-30 |
| US20120129717A1 (en) | 2012-05-24 |
| EP2640742B1 (en) | 2018-08-15 |
| JP6253986B2 (ja) | 2017-12-27 |
| AU2011331129A1 (en) | 2013-05-23 |
| KR101938021B1 (ko) | 2019-01-11 |
| CN103237809A (zh) | 2013-08-07 |
| IL226364A0 (en) | 2013-07-31 |
| AU2011331129B2 (en) | 2016-10-06 |
| US8367586B2 (en) | 2013-02-05 |
| US8728981B2 (en) | 2014-05-20 |
| CN103237809B (zh) | 2016-09-07 |
| EP2640742A1 (en) | 2013-09-25 |
| KR20140015274A (ko) | 2014-02-06 |
| US20140206575A1 (en) | 2014-07-24 |
| PL2640742T3 (pl) | 2019-01-31 |
| WO2012066129A1 (en) | 2012-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2013005614A (es) | Coleccion y metodos para su uso. | |
| IL272831A (en) | Meditopes and meditope-binding antibodies and uses thereof | |
| WO2012135740A3 (en) | Cd37-binding molecules and immunoconjugates thereof | |
| CY1122020T1 (el) | Μορια δεσμευσης σε cd3 ικανα να δεσμευονται σε ανθρωπινα και μη ανθρωπινα cd3 | |
| MX2011012696A (es) | Una coleccion y metodos para su uso. | |
| BR112014012590A8 (pt) | Anticorpos anti-cd98 e métodos de uso dos mesmos | |
| EA201390575A1 (ru) | Неантагонистические egfr-связывающие молекулы и их иммуноконъюгаты | |
| NZ603193A (en) | Antibodies that bind csf1r | |
| EA201590993A1 (ru) | Гетеродимерные иммуноглобулины | |
| NZ601271A (en) | Cd127 binding proteins | |
| NZ628314A (en) | Cd47 antibodies and methods of use thereof | |
| EA201390472A1 (ru) | Новые молекулы, связывающиеся с egfr, и их иммуноконъюгаты | |
| MX342240B (es) | Anticuerpos anti-fgfr4 y metodos de uso. | |
| HRP20151099T8 (xx) | Anti ceacam1 protutijela i metode koje ih koriste | |
| IL233757A0 (en) | Anti '1m e-gi antibodies and methods of using them | |
| SI2591006T1 (sl) | Enoverižne molekule, ki jih lahko obdelujemo in polipeptidi izdelani z njihovo uporabo | |
| EP2566890A4 (en) | ANTI-PAI-1 ANTIBODIES AND METHOD FOR THEIR USE | |
| IL236874B (en) | Anti-kit antibodies and uses thereof | |
| PH12014500841B1 (en) | ANTI-HtrA1 ANTIBODIES AND METHODS OF USE | |
| EP2556766A4 (en) | LOCKING STRIP AND ZIPPER | |
| MX2014014376A (es) | Anticuerpos de anti-biotina y metodos de uso. | |
| UY34160A (es) | Ligandos del receptor trpm8 y su uso en diversos tratamientos | |
| MX2012011829A (es) | Anticuerpos de anti-poliubiquitina y metodos de uso. | |
| NZ605449A (en) | Anti-neuropilin antibodies and methods of use | |
| IL258914A (en) | Antibodies against kidney associated antigen 1 and antigen binding fragments thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |